Sugi Predict

Sugi Predict / Compounds / SCHEMBL12771002

SCHEMBL12771002

SCHEMBL12771002

Oc1ccccc1Pc1ccccc1/C=N/n1cccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ GAA P10253 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CA12 O43570 6/20 0.35
▸ CA2 P00918 6/20 0.35
▸ CA9 Q16790 5/20 0.35
▸ SIRT2 Q8IXJ6 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ AMY1A P0DUB6 3/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12771007 0.85 AMY1A (0.36) POLBCYP1A2CYP2C9CYP2C19MEN1
SCHEMBL12771000 0.81 GAA (0.39) POLBMEN1KMT2AGAAL3MBTL1
SCHEMBL14276077 0.81 CYP1A2 (0.56) POLBCYP1A2CYP2C9CYP2C19MEN1
SCHEMBL5873306 0.81 CYP1A2 (0.56) POLBCYP1A2CYP2C9CYP2C19MEN1
SCHEMBL12770995 0.79 GAA (0.64) POLBCYP1A2CYP2C9CYP2C19MEN1
SCHEMBL12771008 0.78 MAPT (0.36) POLBGAAL3MBTL1KDM4ELMNA
SCHEMBL12770890 0.77 CA12 (0.39) POLBMEN1KMT2AGAAL3MBTL1
SCHEMBL12771006 0.76 ALOX5 (0.31) CYP1A2CYP2C9CYP2C19AMY1A
SCHEMBL12771005 0.75 SMN1; SMN2 (0.38) POLBCYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL12771004 0.75 ALOX5 (0.39) CYP1A2CYP2C9CYP2C19CYP3A4AMY1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915455-B2 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-03-29 — — US disclosed
US-20090143620-A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED 2009-06-04 — — US disclosed
US-7482414-B2 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-01-27 — — US disclosed
US-20070135600-A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135600-A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex AP1M1, OR10J3, AP2M1 POLB 1470/4885CYP1A2 2917/4885CYP2C9 3255/4885
US-20090143620-A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex AP1M1, OR10J3, AP2M1 POLB 1470/4885CYP1A2 2917/4885CYP2C9 3255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.